TMCVX
Price
$17.24
Change
-$0.34 (-1.93%)
Updated
Feb 21 closing price
Net Assets
27.63M
VMVIX
Price
$64.90
Change
-$0.74 (-1.13%)
Updated
Feb 21 closing price
Net Assets
30.89B
Ad is loading...

TMCVX vs VMVIX

Header iconTMCVX vs VMVIX Comparison
Open Charts TMCVX vs VMVIXBanner chart's image
Thrivent Mid Cap Value S
Price$17.24
Change-$0.34 (-1.93%)
VolumeN/A
Net Assets27.63M
Vanguard Mid-Cap Value Index Investor
Price$64.90
Change-$0.74 (-1.13%)
VolumeN/A
Net Assets30.89B
TMCVX vs VMVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TMCVX vs. VMVIX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TMCVX is a StrongSell and VMVIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 30.9B vs. TMCVX (27.6M). VMVIX pays higher dividends than TMCVX: VMVIX (2.03) vs TMCVX (0.91). TMCVX was incepted earlier than VMVIX: TMCVX (5 years) vs VMVIX (19 years). TMCVX is a more actively managed with annual turnover of: 43.00 vs. VMVIX (22.00). TMCVX has a lower initial minimum investment than VMVIX: TMCVX (2000) vs VMVIX (3000). VMVIX annual gain was more profitable for investors over the last year : 12.42 vs. TMCVX (4.24).
TMCVXVMVIXTMCVX / VMVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years19 years-
Gain YTD1.3521.90071%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets27.6M30.9B0%
Annual Yield % from dividends0.912.0345%
Returns for 1 year4.2412.4234%
Returns for 3 years12.1215.3079%
Returns for 5 yearsN/A38.40-
Returns for 10 yearsN/A81.10-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMN27.581.74
+6.73%
AMN Healthcare Services
CUBE41.81-0.17
-0.40%
CubeSmart
MLR60.11-0.79
-1.30%
Miller Industries
AEYE15.21-0.81
-5.06%
AudioEye
INM3.12-0.27
-7.96%
InMed Pharmaceuticals Inc